secwatch.observer — SEC 8-K summary
======================================

Issuer:     Seer, Inc. (SEER)
CIK:        0001726445
Form:       8-K
Filed at:   2024-08-16T23:59:59+00:00
Accession:  0000950170-24-098074
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Seer appoints Nicolas Roelofs to board as Lead Independent Director effective Aug 13, 2024
--------------------------------------------------------------------------------

- Roelofs replaces David Hallal as Lead Independent Director and joins CG&N and Science & Technology committees.
- Initial equity award of 69,470 stock options and 46,886 RSUs, vesting in three equal annual installments.
- Roelofs brings 35+ years experience including president of Agilent Life Sciences Group.
- No arrangement or understanding with any person regarding his election as director.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1726445/000095017024098074/0000950170-24-098074-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1726445/000095017024098074/ck0001726445-20240813.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-098074

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer